sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÓÕ·¢ÐÔϵͳÐÔºì°ßÀÇ´¯¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ÓÕ·¢ÐÔϵͳÐÔºì°ßÀÇ´¯¶¯ÎïÄ£×Ó

ǰÑÔ

ϵͳÐÔºì°ßÀÇ´¯(systemic lupus erythematosus,SLE)ÊÇÒ»ÖÖ×ÔÉíÃâÒ߽鵼µÄ £¬ÒÔÃâÒßÐÔÑ×֢Ϊͻ³öÌåÏÖµÄ £¬ÀÛ¼°¶àϵͳ¡¢¶àÆ÷¹Ù¡¢¶à×éÖ¯Ë𺦵ÄÂýÐÔÈ«ÉíÐÔ¼²²¡ ¡£ÑªÇåÖб£´æÒÔ¿¹ºË¿¹Ìå¡¢¿¹dsDNA¿¹ÌåΪ´ú±íµÄ¶àÖÖ×ÔÉí¿¹Ìå ¡£ÁÙ´²ÌåÏÖΪºã¾ÃµÍ¡¢Öжȷ¢ÈÈ £¬·¦Á¦¡¢ÌåÖØ¼õÇá £¬Ãæ¼Õ²¿µûÐκì°ß £¬ÊàŦÌÛÍ´ £¬ÐİüÑ× £¬¼äÖÊÐÔ·ÎÑ× £¬ÀÇ´¯ÐÔÉöÑס¢Éñ¾­ÏµÍ³¸Ä±äµÈÈ«ÉíÐÔÖ¢×´ ¡£»¯Ñé¼ì²éѪºìÂѰ×Ͻµ £¬°×ϸ°û»òѪС°åïÔÌ­ £¬»¼ÕßѪÇå¿É²éµ½¶àÖÖ¿¹ºË¿¹Ìå¡¢¿¹Á×Ö¬¿¹ÌåºÍ¿¹×é֯ϸ°û¿¹Ìå ¡£ÑªÇå×ܲ¹Ì庬ÃÍϽµ £¬ÓÈÆäÊÇC3º¬Á¿µÍÏÂÌåÏÖΪÔ˶¯ÆÚ ¡£

SLEÊÇÒ»ÖÖ³£¼ûµÄÄÑÖÎÐÔ¼²²¡ £¬ËäÈ»ÏÖÒÑÃ÷È·SLEÊÇÒ»ÖÖ×ÔÉíÃâÒß²¡ £¬µ«È·Çв¡ÒòºÍ·¢²¡»úÖÆÉÐδÍêÈ«ÆÊÎö ¡£Ò»Ñùƽ³£ÒÔΪÖ÷ÒªÓëÒÅ´«ÓÐ¹Ø £¬ÇéÐÎÒòËØÊÇÒ»¸ö´ÎÒªÒòËØ ¡£ÓÉÓÚSLE»¼ÕßÅ®ÐÔÏÔ×ŶàÓÚÄÐÐÔ(9:1),XȾɫÌå±àÂëµÄ»ùÒò¿ÉÄÜÓë´Ë²¡ÓÐ¹Ø ¡£ÕýÓÉÓÚÔÆÔÆ £¬ÔËÓÃÖÖÖÖ¶¯ÎïÄ£×Ó´Ó²î±ð½Ç¶È¶Ô̽ÌÖ±¾²¡µÄ·¢²¡»úÖÆ¡¢²¡Àíת±äºÍÖÎÁÆÒªÁì¾ßÓÐÖ÷ÒªÒâÒå ¡£

SLE¶¯ÎïÄ£×Ó¿É·ÖΪÓÕ·¢ÐÔ¶¯ÎïÄ£×Ó¡¢×Ô¾õÐÔ¶¯ÎïÄ£×ӺͻùÒòÐÞÊζ¯ÎïÄ£×Ó3Àà ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

½µÖ²Íé(pristane)ÊÇÖеȳ¤¶ÈµÄÍéÁ´ £¬Æä×÷ÓûúÖÆÓë×ô¼ÁÀàËÆ £¬¿ÉÒýÆðÑ×Ö¢ºÍÔöÇ¿ÃâÒß·´Ó¦ ¡£Ð¡Êó¸¹Ç»×¢Éä½µÖ²Íéºó £¬½µÖ²ÍéÓ͵α»µ¥ºËÍÌÊÉϸ°ûÍÌÊÉ £¬T¡¢BÁܰÍϸ°ûÔöֳȺ¼¯ÐγÉÈâÑ¿Ö× ¡£Tϸ°û¸ß¶È»î»¯ £¬Bϸ°û·´Ó¦ÐÔÔö¸ß £¬±¬·¢¶àÖÖ×ÔÉí¿¹Ìå ¡£ÒàÓÐÑо¿ÒÔΪ½µÖ²Íé¿Éͨ¹ýÏßÁ£ÌåËðÉË;¾¶ÓÕ·¢Ï¸°ûµòÍö £¬±¬·¢µÄºË¿¹Ô­Æô¶¯ÁË×ÔÉíÃâÒß·´Ó¦ ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

 6¡«8ÖÜBALB/c´ÆÐÔСÊóÒ»´ÎÐÔ¸¹Ç»×¢Éä½µÖ²Íé0.5ml ¡£×¢Éäǰ¼°×¢Éäºóÿ2ÖܽÓÄÉСÊóÍâÖÜѪ £¬¼ì²âѪÇåÖÐ×ÔÉí¿¹Ì壨¿¹dsDNA¡¢¿¹smRNPºÍ¿¹ºËÌÇÌåP0) ¡£

¡¾Ä£×ÓÌØµã¡¿£º

½µÖ²Íé´¦Öóͷ£×éѪÇåÖÐ×ÜlgG¼°¿¹dsDNA¡¢¿¹ºËÌÇÌåP0¼°¿¹smRNP¿¹Ì庬Á¿´ÓµÚ2¸öÔÂÆð×îÏÈÒ»Á¬ÉÏÉý £¬×ÔµÚ3¸öÔÂÆð¿¹ºËÌÇÌåP0µÄ×ÔÉí¿¹ÌåµÄˮƽ¿ÉÏÔןßÓÚÒõÐÔ±ÈÕÕ×é ¡£6¸öÔºó½µÖ²Íé´¦Öóͷ£×éСÊóÉöСÇòÖб£´æ´ó×ÚIgG³Á»ý £¬·ºÆðÖжȵ½ÖضȵÄÊàŦËðÉË £¬Á÷ʽϸ°ûÒǼì²â¸¹Ç»Ï¸°ûÖÐIFN-αÉøÍ¸Ï¸°ûÑÇȺµÄ±ÈÀý £¬½µÖ²Íé´¦Öóͷ£×éµÄϸ°ûÊý×îÏÔÖø¸ßÓÚÒõÐÔ±ÈÕÕ×é ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

´ËÄ£×Ó¿ÉÓÃÓÚSLE²¡Òò¡¢·¢²¡»úÖÆ¡¢×ÔÉíÃâÒßÐÔ¼²²¡µÄÃâÒßµ÷Àí¡¢ÃâÒ߸´ºÏÎïÐÔÉöÑס¢ÖÎÁÆSLEÒ©ÎïµÄҩЧѧÑо¿µÈ ¡£×¢ÖØ£º¢ÙËäÈ»ÓýµÖ²Íé¿ÉÔÚ²î±ð½ü½»ÏµÐ¡ÊóÓÕµ¼SLE £¬µ«¸÷Ʒϵ±¬·¢×ÔÉí¿¹ÌåµÄ¼¸Âʺ͵ζÈÓвî±ð £¬BALB/cByJ¡¢DBA/1¡¢C57BL/6J¾ù¿É±¬·¢¿¹Su¡¢¿¹RNP/Sm ¿¹Ì壨°Ð¿¹Ô­Ö÷ҪΪU1RNP£©¡¢¿¹dsDNA¿¹Ìå¡¢¿¹ssDNA¿¹Ìå¡¢¿¹×éÂѰ׿¹Ìå £¬¶øA¡¢SW¡¢C57BL/6J¡¢SJL/JСÊó¿É±¬·¢¿¹ºËÌÇÌåP¿¹Ì壻¢Ú´ÆÐÔ½ÏÐÛÐÔÒ×ÓÕµ¼³öÀÇ´¯Ñù²¡±ä ¡£

  

²Î¿¼ÎÄÏ×£º

1.¬ÁÕ £¬ÞÉ»ª¹ú £¬ÎâºñÉú£®»î»¯ÁܰÍϸ°û¼°ÆäȾɫÖÊÓÕµ¼¿¹ºË¿¹ÌåÌìÉú£®ÖлªÎ¢ÉúÎïѧºÍÃâÒßѧÔÓÖ¾ £¬1999, 19(1):44-46

2.Àî½ðÖ¦ £¬¶¡öÁ £¬Merim Boukherouba £¬µÈ£®PristaneÓÕµ¼Ð¡ÊóϵͳÐÔºì°àÀÇ´¯¶¯ÎïÄ£×ÓµÄÑо¿£®Ï¸°ûÓë·Ö×ÓÃâÒßѧÔÓÖ¾ £¬2011,27(2): 119-122

3.ÂÞÑåÑå £¬ÁÖÓÐÀ¤ £¬»Æ´äÀö £¬µÈ£®¸Îϸ°ûÖÊÂѰ×ÓÕµ¼ÏµÍ³ÐÔºì°ßÀÇ´¯ÍÃÄ£×ÓµÄʵÑéÑо¿. ÃâÒßѧÔÓÖ¾ £¬2011,27 (8):710-714

4.Bubier JA,Sproule TJ,Foreman  O,el al.  A  critical role for TL-21 receptor signaling in the pathogenesis of systemic lupus erythemalosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A,2009, 106(5): 1518-1523

5.Chen J, Kubalak SW, Chien KR. Ventricular muscle­restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development, 1998, 125 (10): 1943-1949

6.Dubois EL,Horowitz RE,Demopoulos HB,et al. NZB/ NZW mice as a model of systemic lupus erythematosus£®JAMA, 1966, 195 (4):285-289

7.Han B,Moore PA, Wu J,et al. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus­like synclrome. Arthritis Rheum, 2007,56 (11):3748-3758

8.Satoh M. Richards HB, Shaheen VM, et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoanlibodies by pristane. Clin Exp lmmunol, 2000, 121(2):399-405

9.Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristine. J Exp Med, 1994, 180 (6):2341-2346

10.Takai T, Ono M, Hikida M, et al. Augmented humoral and anaphylaclic responses in Fc gamma R¢ò-deficienl mice. Nature, 1996,379(6563):346-349

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ÓÕ·¢ÐÔϵͳÐÔºì°ßÀÇ´¯¶¯ÎïÄ£×Ó
ÓÕ·¢ÐÔϵͳÐÔºì°ßÀÇ´¯¶¯ÎïÄ£×Ó

ǰÑÔ

ϵͳÐÔºì°ßÀÇ´¯(systemic lupus erythematosus,SLE)ÊÇÒ»ÖÖ×ÔÉíÃâÒ߽鵼µÄ £¬ÒÔÃâÒßÐÔÑ×֢Ϊͻ³öÌåÏÖµÄ £¬ÀÛ¼°¶àϵͳ¡¢¶àÆ÷¹Ù¡¢¶à×éÖ¯Ë𺦵ÄÂýÐÔÈ«ÉíÐÔ¼²²¡ ¡£ÑªÇåÖб£´æÒÔ¿¹ºË¿¹Ìå¡¢¿¹dsDNA¿¹ÌåΪ´ú±íµÄ¶àÖÖ×ÔÉí¿¹Ìå ¡£ÁÙ´²ÌåÏÖΪºã¾ÃµÍ¡¢Öжȷ¢ÈÈ £¬·¦Á¦¡¢ÌåÖØ¼õÇá £¬Ãæ¼Õ²¿µûÐκì°ß £¬ÊàŦÌÛÍ´ £¬ÐİüÑ× £¬¼äÖÊÐÔ·ÎÑ× £¬ÀÇ´¯ÐÔÉöÑס¢Éñ¾­ÏµÍ³¸Ä±äµÈÈ«ÉíÐÔÖ¢×´ ¡£»¯Ñé¼ì²éѪºìÂѰ×Ͻµ £¬°×ϸ°û»òѪС°åïÔÌ­ £¬»¼ÕßѪÇå¿É²éµ½¶àÖÖ¿¹ºË¿¹Ìå¡¢¿¹Á×Ö¬¿¹ÌåºÍ¿¹×é֯ϸ°û¿¹Ìå ¡£ÑªÇå×ܲ¹Ì庬ÃÍϽµ £¬ÓÈÆäÊÇC3º¬Á¿µÍÏÂÌåÏÖΪÔ˶¯ÆÚ ¡£

SLEÊÇÒ»ÖÖ³£¼ûµÄÄÑÖÎÐÔ¼²²¡ £¬ËäÈ»ÏÖÒÑÃ÷È·SLEÊÇÒ»ÖÖ×ÔÉíÃâÒß²¡ £¬µ«È·Çв¡ÒòºÍ·¢²¡»úÖÆÉÐδÍêÈ«ÆÊÎö ¡£Ò»Ñùƽ³£ÒÔΪÖ÷ÒªÓëÒÅ´«ÓÐ¹Ø £¬ÇéÐÎÒòËØÊÇÒ»¸ö´ÎÒªÒòËØ ¡£ÓÉÓÚSLE»¼ÕßÅ®ÐÔÏÔ×ŶàÓÚÄÐÐÔ(9:1),XȾɫÌå±àÂëµÄ»ùÒò¿ÉÄÜÓë´Ë²¡ÓÐ¹Ø ¡£ÕýÓÉÓÚÔÆÔÆ £¬ÔËÓÃÖÖÖÖ¶¯ÎïÄ£×Ó´Ó²î±ð½Ç¶È¶Ô̽ÌÖ±¾²¡µÄ·¢²¡»úÖÆ¡¢²¡Àíת±äºÍÖÎÁÆÒªÁì¾ßÓÐÖ÷ÒªÒâÒå ¡£

SLE¶¯ÎïÄ£×Ó¿É·ÖΪÓÕ·¢ÐÔ¶¯ÎïÄ£×Ó¡¢×Ô¾õÐÔ¶¯ÎïÄ£×ӺͻùÒòÐÞÊζ¯ÎïÄ£×Ó3Àà ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

½µÖ²Íé(pristane)ÊÇÖеȳ¤¶ÈµÄÍéÁ´ £¬Æä×÷ÓûúÖÆÓë×ô¼ÁÀàËÆ £¬¿ÉÒýÆðÑ×Ö¢ºÍÔöÇ¿ÃâÒß·´Ó¦ ¡£Ð¡Êó¸¹Ç»×¢Éä½µÖ²Íéºó £¬½µÖ²ÍéÓ͵α»µ¥ºËÍÌÊÉϸ°ûÍÌÊÉ £¬T¡¢BÁܰÍϸ°ûÔöֳȺ¼¯ÐγÉÈâÑ¿Ö× ¡£Tϸ°û¸ß¶È»î»¯ £¬Bϸ°û·´Ó¦ÐÔÔö¸ß £¬±¬·¢¶àÖÖ×ÔÉí¿¹Ìå ¡£ÒàÓÐÑо¿ÒÔΪ½µÖ²Íé¿Éͨ¹ýÏßÁ£ÌåËðÉË;¾¶ÓÕ·¢Ï¸°ûµòÍö £¬±¬·¢µÄºË¿¹Ô­Æô¶¯ÁË×ÔÉíÃâÒß·´Ó¦ ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

 6¡«8ÖÜBALB/c´ÆÐÔСÊóÒ»´ÎÐÔ¸¹Ç»×¢Éä½µÖ²Íé0.5ml ¡£×¢Éäǰ¼°×¢Éäºóÿ2ÖܽÓÄÉСÊóÍâÖÜѪ £¬¼ì²âѪÇåÖÐ×ÔÉí¿¹Ì壨¿¹dsDNA¡¢¿¹smRNPºÍ¿¹ºËÌÇÌåP0) ¡£

¡¾Ä£×ÓÌØµã¡¿£º

½µÖ²Íé´¦Öóͷ£×éѪÇåÖÐ×ÜlgG¼°¿¹dsDNA¡¢¿¹ºËÌÇÌåP0¼°¿¹smRNP¿¹Ì庬Á¿´ÓµÚ2¸öÔÂÆð×îÏÈÒ»Á¬ÉÏÉý £¬×ÔµÚ3¸öÔÂÆð¿¹ºËÌÇÌåP0µÄ×ÔÉí¿¹ÌåµÄˮƽ¿ÉÏÔןßÓÚÒõÐÔ±ÈÕÕ×é ¡£6¸öÔºó½µÖ²Íé´¦Öóͷ£×éСÊóÉöСÇòÖб£´æ´ó×ÚIgG³Á»ý £¬·ºÆðÖжȵ½ÖضȵÄÊàŦËðÉË £¬Á÷ʽϸ°ûÒǼì²â¸¹Ç»Ï¸°ûÖÐIFN-αÉøÍ¸Ï¸°ûÑÇȺµÄ±ÈÀý £¬½µÖ²Íé´¦Öóͷ£×éµÄϸ°ûÊý×îÏÔÖø¸ßÓÚÒõÐÔ±ÈÕÕ×é ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

´ËÄ£×Ó¿ÉÓÃÓÚSLE²¡Òò¡¢·¢²¡»úÖÆ¡¢×ÔÉíÃâÒßÐÔ¼²²¡µÄÃâÒßµ÷Àí¡¢ÃâÒ߸´ºÏÎïÐÔÉöÑס¢ÖÎÁÆSLEÒ©ÎïµÄҩЧѧÑо¿µÈ ¡£×¢ÖØ£º¢ÙËäÈ»ÓýµÖ²Íé¿ÉÔÚ²î±ð½ü½»ÏµÐ¡ÊóÓÕµ¼SLE £¬µ«¸÷Ʒϵ±¬·¢×ÔÉí¿¹ÌåµÄ¼¸Âʺ͵ζÈÓвî±ð £¬BALB/cByJ¡¢DBA/1¡¢C57BL/6J¾ù¿É±¬·¢¿¹Su¡¢¿¹RNP/Sm ¿¹Ì壨°Ð¿¹Ô­Ö÷ҪΪU1RNP£©¡¢¿¹dsDNA¿¹Ìå¡¢¿¹ssDNA¿¹Ìå¡¢¿¹×éÂѰ׿¹Ìå £¬¶øA¡¢SW¡¢C57BL/6J¡¢SJL/JСÊó¿É±¬·¢¿¹ºËÌÇÌåP¿¹Ì壻¢Ú´ÆÐÔ½ÏÐÛÐÔÒ×ÓÕµ¼³öÀÇ´¯Ñù²¡±ä ¡£

  

²Î¿¼ÎÄÏ×£º

1.¬ÁÕ £¬ÞÉ»ª¹ú £¬ÎâºñÉú£®»î»¯ÁܰÍϸ°û¼°ÆäȾɫÖÊÓÕµ¼¿¹ºË¿¹ÌåÌìÉú£®ÖлªÎ¢ÉúÎïѧºÍÃâÒßѧÔÓÖ¾ £¬1999, 19(1):44-46

2.Àî½ðÖ¦ £¬¶¡öÁ £¬Merim Boukherouba £¬µÈ£®PristaneÓÕµ¼Ð¡ÊóϵͳÐÔºì°àÀÇ´¯¶¯ÎïÄ£×ÓµÄÑо¿£®Ï¸°ûÓë·Ö×ÓÃâÒßѧÔÓÖ¾ £¬2011,27(2): 119-122

3.ÂÞÑåÑå £¬ÁÖÓÐÀ¤ £¬»Æ´äÀö £¬µÈ£®¸Îϸ°ûÖÊÂѰ×ÓÕµ¼ÏµÍ³ÐÔºì°ßÀÇ´¯ÍÃÄ£×ÓµÄʵÑéÑо¿. ÃâÒßѧÔÓÖ¾ £¬2011,27 (8):710-714

4.Bubier JA,Sproule TJ,Foreman  O,el al.  A  critical role for TL-21 receptor signaling in the pathogenesis of systemic lupus erythemalosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A,2009, 106(5): 1518-1523

5.Chen J, Kubalak SW, Chien KR. Ventricular muscle­restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development, 1998, 125 (10): 1943-1949

6.Dubois EL,Horowitz RE,Demopoulos HB,et al. NZB/ NZW mice as a model of systemic lupus erythematosus£®JAMA, 1966, 195 (4):285-289

7.Han B,Moore PA, Wu J,et al. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus­like synclrome. Arthritis Rheum, 2007,56 (11):3748-3758

8.Satoh M. Richards HB, Shaheen VM, et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoanlibodies by pristane. Clin Exp lmmunol, 2000, 121(2):399-405

9.Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristine. J Exp Med, 1994, 180 (6):2341-2346

10.Takai T, Ono M, Hikida M, et al. Augmented humoral and anaphylaclic responses in Fc gamma R¢ò-deficienl mice. Nature, 1996,379(6563):346-349

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿